Deutsche Bank Maintains Hold on GoodRx Holdings, Raises Price Target to $8
Deutsche Bank analyst George Hill maintains GoodRx Holdings (NASDAQ:GDRX) with a Hold and raises the price target from $7 to $8.
Wells Fargo Maintains Equal-Weight on GoodRx Holdings, Raises Price Target to $6
Wells Fargo analyst Stan Berenshteyn maintains GoodRx Holdings (NASDAQ:GDRX) with a Equal-Weight and raises the price target from $5.5 to $6.
Goldman Sachs Maintains Neutral on GoodRx Holdings, Lowers Price Target to $7
Goldman Sachs analyst Eric Sheridan maintains GoodRx Holdings (NASDAQ:GDRX) with a Neutral and lowers the price target from $8 to $7.
The Latest Analyst Ratings for GoodRx Holdings
GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Barclays Maintains Overweight on GoodRx Holdings, Lowers Price Target to $8
Barclays analyst Steve Valiquette maintains GoodRx Holdings (NASDAQ:GDRX) with a Overweight and lowers the price target from $9 to $8.
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24.
Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250.
PVH, Five Below, Okta And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly lower, with the Dow Jones dropping over 300 points on Thursday. Here are some big stocks recording gains in today’s session.
Benzinga’s Top Ratings Upgrades, Downgrades For December 1, 2022
Upgrades Northcoast Research upgraded the previous rating for SpartanNash Co (NASDAQ:SPTN) from Neutral to Buy. SpartanNash earned $0.55…